Impact of sarcopenia on daily functioning: a cross-sectional study among older inpatients.
Cognition
Functional status
Geriatrics
Older adults
Sarcopenia
Journal
Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
16
02
2022
accepted:
08
06
2022
pubmed:
7
7
2022
medline:
14
9
2022
entrez:
6
7
2022
Statut:
ppublish
Résumé
Geriatric patients with sarcopenia are at increased risk for functional decline with loss of independence in daily living. This cross-sectional study aims to investigate the impact of sarcopenia on different domains of functional status in hospitalized geriatric patients. Sarcopenia was assessed at hospital admission using the recommendations of the European Working Group on Sarcopenia in Older People 2 (EWGSOP2). Body impedance analysis (BIA) was performed to determine muscle mass, and a pneumatic hand dynamometer was used to assess muscle strength. The functional independence measure (FIM) score, an 18-item tool exploring an individual's physical, cognitive and social functions, was used to measure functional status. In 305 included inpatients with a median age of 84.0 years (65.6% female), prevalence of sarcopenia was 22.6%. Overall, sarcopenic patients had significant lower FIM scores compared to non-sarcopenic patients (p = 0.006). An association with sarcopenia was found for the FIM items bed/chair/wheelchair transfer (p = 0.047), transfer to toilet (p = 0.048), locomotion (p = 0.001), climbing stairs (p = 0.012), comprehension (p = 0.029), and social interaction (p = 0.028). In hospitalized geriatric patients, sarcopenia was found to be associated with both cognitive and mobility domains, but not with self-care domains of the FIM score. Therefore, when addressing sarcopenia in inpatients, tailored and multi-dimensional training interventions mainly should focus on motor-cognitive abilities.
Sections du résumé
BACKGROUND AND AIM
OBJECTIVE
Geriatric patients with sarcopenia are at increased risk for functional decline with loss of independence in daily living. This cross-sectional study aims to investigate the impact of sarcopenia on different domains of functional status in hospitalized geriatric patients.
METHODS
METHODS
Sarcopenia was assessed at hospital admission using the recommendations of the European Working Group on Sarcopenia in Older People 2 (EWGSOP2). Body impedance analysis (BIA) was performed to determine muscle mass, and a pneumatic hand dynamometer was used to assess muscle strength. The functional independence measure (FIM) score, an 18-item tool exploring an individual's physical, cognitive and social functions, was used to measure functional status.
RESULTS
RESULTS
In 305 included inpatients with a median age of 84.0 years (65.6% female), prevalence of sarcopenia was 22.6%. Overall, sarcopenic patients had significant lower FIM scores compared to non-sarcopenic patients (p = 0.006). An association with sarcopenia was found for the FIM items bed/chair/wheelchair transfer (p = 0.047), transfer to toilet (p = 0.048), locomotion (p = 0.001), climbing stairs (p = 0.012), comprehension (p = 0.029), and social interaction (p = 0.028).
CONCLUSION
CONCLUSIONS
In hospitalized geriatric patients, sarcopenia was found to be associated with both cognitive and mobility domains, but not with self-care domains of the FIM score. Therefore, when addressing sarcopenia in inpatients, tailored and multi-dimensional training interventions mainly should focus on motor-cognitive abilities.
Identifiants
pubmed: 35794312
doi: 10.1007/s40520-022-02175-z
pii: 10.1007/s40520-022-02175-z
pmc: PMC9464162
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2041-2046Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022. The Author(s).
Références
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
EMBO J. 2019 Dec 16;38(24):e102154
pubmed: 31736098
J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):28-36
pubmed: 27066316
Healthcare (Basel). 2020 Aug 06;8(3):
pubmed: 32781673
Adv Clin Rehabil. 1987;1:6-18
pubmed: 3503663
Am J Med. 2006 Jun;119(6):526.e9-17
pubmed: 16750969
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
Cell Metab. 2016 Aug 9;24(2):332-40
pubmed: 27345423
J Nutr Health Aging. 2021;25(1):64-70
pubmed: 33367464
Arch Neurol. 2004 May;61(5):668-72
pubmed: 15148142
Australas J Ageing. 2018 Mar;37(1):62-67
pubmed: 29314585
Nutrition. 2019 May;61:111-118
pubmed: 30710883
Clin Nutr. 2018 Dec;37(6 Pt A):2022-2028
pubmed: 28987469
Nutrients. 2020 Jun 29;12(7):
pubmed: 32610491
J Am Geriatr Soc. 1991 Feb;39(2):142-8
pubmed: 1991946
Geriatr Gerontol Int. 2017 Jul;17(7):1048-1056
pubmed: 27273820
Age Ageing. 2011 Jul;40(4):469-75
pubmed: 21565862
J Am Med Dir Assoc. 2011 Jul;12(6):403-9
pubmed: 21640657
Eur J Clin Nutr. 2021 Apr;75(4):653-660
pubmed: 33060812
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):512-514
pubmed: 27891296
J Nutr Health Aging. 2014 Mar;18(3):284-90
pubmed: 24626756
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Nutrition. 2019 Feb;58:1-6
pubmed: 30273819
J Cell Physiol. 2021 Apr;236(4):2393-2412
pubmed: 32885426
Geriatr Gerontol Int. 2019 Nov;19(11):1124-1128
pubmed: 31591820
Clin Nutr. 2003 Jun;22(3):321-36
pubmed: 12765673
Iran J Public Health. 2018 Mar;47(3):327-334
pubmed: 29845019
Age Ageing. 2016 Sep;45(5):602-8
pubmed: 27126327